Abstract
A series of 5-substituted 5-phenylhydantoins was synthesized and their UV absorption spectra were recorded in the region 200–400 nm in selected solvents of different polarity. The effects of solvent dipolarity/polarizability and solvent–solute hydrogen-bonding interactions were analyzed by means of the linear solvation energy relationship concept proposed by Kamlet and Taft. The lipophilicities of the investigated hydantoins were estimated by calculation of their log P values. The quantitative relationship between the ratio of the contributions of specific solvent interactions and the corresponding lipophilicity parameter is discussed. The correlation equations were combined with the corresponding ED50 values and different physicochemical parameters to generate new equations that demonstrate the reasonable relationships between solute–solvent interactions and the structure–activity parameters. In order to determine a spectroscopic assignment of the absorption bands in different solvents, quantum chemical calculations were done.
Graphical abstract
Similar content being viewed by others
References
Merritt HH, Putnam TJ (1938) Arch Neurol Psychiatry 39:1003
Anger T, Madge DJ, Mulla M, Riddall D (2001) J Med Chem 44:115
Ahmed KI (1998) Carbohydr Res 306:567
Comber RN, Reynolds RC, Friedrich JD, Manguikian RA, Buckheit RW, Truss JJW, Shannon WM, Secrist JA (1992) J Med Chem 35:3567
Tompkins E (1986) J Med Chem 29:855
Menendez JC, Diaz MP, Bellver C, Sollhuber MM (1992) Eur J Med Chem 27:61
Scholl S, Koch A, Henning D, Kempter G, Kleinpeter E (1999) Struct Chem 10:355
Yamagami C, Sonoda C, Takao N, Tanaka M, Yamada J, Horisaka K, Fujita T (1982) 30:4175
Meldrum BS (1997) Epilepsia 38:S7
Smythies JR (1980) Receptor modeling for anticonvulsant and convulsant drugs. In: Glaser GH, Penry JK, Kiffin J, Woodbury DM (eds) Advances in neurology, vol 27. Raven, New York, p 207
Oliferenko PV, Oliferenko AA, Poda G, Palyulin VA, Zefirov NS, Katrizky AR (2009) J Chem Inf Model 49:634
Van de Waterbeemd H, Gifford E (2003) Nat Rev Drug Discov 2:192
Poupaert JH, Vandervorst D, Guiot P, Moustafa MMM, Dumont P (1984) J Med Chem 27:76
Cortes S, Liao ZK, Watson D, Kohn H (1985) J Med Chem 28:601
Heymons A, Persch W (1959) GB Patent 823517
Vida JA, O’Dea MH, Samour CM, Reinhard JF (1975) J Med Chem 18:383
Kamlet MJ, Abboud JL, Abraham MH, Taft RW (1983) J Org Chem 48:2877
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2003) Gaussian 03, revision B.01. Gaussian, Pittsburgh
Stewart JJP (2009) MOPAC 2009. Stewart computational chemistry, version 10.153W. Available via http://OpenMOPAC.net. Accessed 30 June 2010
Kleinpeter E (1997) Struct Chem 8:161
Đaković-Sekulić T, Despotović V, Ušćumlić G (2010) J Planar Chromatogr 23:201
Abraham MH, Lieb WR, Franks NP (1991) J Pharm Sci 80:719
Banjac N, Ušćumlić G, Valentić N, Mijin D (2007) J Solut Chem 36:869
Hadjipavlou-Litina D (1998) Med Res Rev 18:91
Bucherer HT, Lieb VA (1934) J Prakt Chem 141:5
Murray RG, Whitehead DM, Le Strat F, Conway SJ (2008) Org Biomol Chem 6:988
Thompson TJ, Bedell HL, Buffett GM (1925) J Am Chem Soc 47:874
Chemische Fabrik von Heyden (1921) DE Patent 335 994
Tiffeneau M, Tchoubar MB, Saiaslambert M, LeTellier-Dupre M (1947) Bull Soc Chim Fr 445
Henze HR (1946) US Patent 2 409 754
Novelli A, De Santis AM (1968) J Med Chem 11:176
Pedretti A, Villa L, Vistoli GJ (2004) Comp Aid Mol Des 18:167. VegaZZ 2.3.1. Avaible via http://www.ddl.unimi.it. Accessed 30 June 2010
Unger SH, Hansch C (1976) Progr Phys Org Chem 12:91
Acknowledgments
This work was supported by the Ministry of Science and Technological Development of Serbia (Project Number 172013).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Trišović, N., Valentić, N., Erović, M. et al. Synthesis, structure, and solvatochromic properties of pharmacologically active 5-substituted 5-phenylhydantoins. Monatsh Chem 142, 1227–1234 (2011). https://doi.org/10.1007/s00706-011-0639-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-011-0639-7